Human-Centric Drug Discovery: Connecting Discovery Decisions to Clinical Success

Drug discovery is evolving as organizations seek more predictive ways to assess efficacy, safety, and clinical relevance earlier in development. Advances in New Approach Methodologies (NAMs), human-relevant biology, translational biomarkers, and data-driven approaches are creating new opportunities to improve decision-making while reducing uncertainty.

This webinar will explore how leading drug developers are applying human-centric approaches to strengthen discovery strategies and improve confidence in advancing therapeutic candidates. Attendees will gain perspectives on the growing role of NAMs in efficacy and safety assessment, the challenges of translating biological insights into clinical outcomes, and emerging approaches for building stronger connections between discovery and development.

As the industry continues to move toward more integrated and patient-relevant research models, connecting human biology, scientific expertise, data, and clinical insight has become increasingly important for informing decisions throughout the R&D journey.

What you will learn:

•  Evaluate how NAMs and human-relevant models are being applied to efficacy and safety assessment
• Apply human-centric biology strategies to support earlier and more informed discovery decisions.

• Assess approaches for improving translational confidence when selecting and advancing therapeutic candidates.
• Understand how integrating discovery, data, and clinical insight can help strengthen development strategies.